NeuroPace (NPCE) Research & Development (2020 - 2026)
NeuroPace (NPCE) posted quarterly Research & Development of $7.2 million for Q1 2026, down 3.37% year-over-year from $7.4 million in Q1 2025, and down 34.26% quarter-over-quarter from $10.9 million in Q4 2025.
NeuroPace (NPCE) Research & Development (2020 - 2026) Analysis & Trends
NeuroPace's Research & Development history runs 7 years deep, the most recent figure standing at $7.2 million for Q1 2026.
- In Q1 2026, Research & Development fell 3.37% year-over-year to $7.2 million; the TTM figure through Mar 2026 stood at $37.6 million (up 78.39% YoY), while the FY2025 annual figure was $46.6 million, up 96.93% from the prior year.
- Research & Development for Q1 2026 stood at $7.2 million, down from $10.9 million in the prior quarter.
- The five-year high for Research & Development was $12.6 million in Q3 2025, with the low at -$6.1 million in Q4 2024.
- The 5-year median for Research & Development is $5.7 million (2022), against an average of $6.3 million.
- The sharpest annual moves came in 2024 and 2025: Research & Development slumped 212.8% in 2024, then soared 280.31% in 2025.
- NeuroPace's Research & Development stood at $5.1 million in 2022, then rose by 5.66% to $5.4 million in 2023, then plunged by 212.8% to -$6.1 million in 2024, then jumped by 280.31% to $10.9 million in 2025, then plunged by 34.26% to $7.2 million in 2026.
- Business Quant data shows NPCE's Research & Development at $7.2 million in Q1 2026, $10.9 million in Q4 2025, and $12.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 129.71 Bn | 126.23 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 120.07 Bn | 110.85 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 34.03 Bn | 31.92 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.51 Bn | 23.19 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn | 28.60 Mn |
| 10 | NeuroPace | 483.26 Mn | 431.56 Mn | 18.91 Mn | 12.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.12 Mn |
| Mar 31, 2026 | 7.19 Mn |
| Dec 31, 2025 | 10.94 Mn |
| Sep 30, 2025 | 12.60 Mn |
| Jun 30, 2025 | 6.85 Mn |
| Mar 31, 2025 | 7.44 Mn |
| Dec 31, 2024 | -6.07 Mn |
| Sep 30, 2024 | 9.93 Mn |
| Jun 30, 2024 | 9.76 Mn |
| Mar 31, 2024 | 5.78 Mn |
| Dec 31, 2023 | 5.38 Mn |
| Sep 30, 2023 | 4.80 Mn |
| Jun 30, 2023 | 5.34 Mn |
| Mar 31, 2023 | 5.26 Mn |
| Dec 31, 2022 | 5.09 Mn |
| Sep 30, 2022 | 5.61 Mn |
| Jun 30, 2022 | 5.67 Mn |
| Mar 31, 2022 | 5.58 Mn |
| Dec 31, 2021 | 5.35 Mn |
| Sep 30, 2021 | 4.33 Mn |